StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for MAIA Biotechnology

MAIA Biotechnology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More MAIA Biotechnology figures

See a number that looks wrong?